Skip to main content
Equibles
IVPR logo

IVPR · Inspire Veterinary Partners, Inc. · Metrics

Track IVPR — free

Use IVPR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IVPR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 +0.00 (+0.00%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Nov 12, 2025

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for the next twelve months from the date these financial statements were issued.”
View the 10-Q filed Nov 12, 2025
Market Cap
$376
Shares
3.76M
Volume · Oct 20 31.05K Avg daily vol (3M) 212.26K

IVPR metrics

57 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.00
Market cap
$376

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
+0.0%
Price change (3M)
-90.0%
Price change (6M)
-94.4%
Price change (YTD)
-99.8%
Price change (1Y)
-100.0%
Trailing year
Price change (5Y)
—
52-week high
$0.96
52-week low
$0.00
Change from 52-week high
-100.0%
Change from 52-week low
+0.0%
Annualized volatility
460.0%
Annualized volatility (3M)
—
Beta
0.7
RSI (14D)
44.6
Price vs SMA 50
-19.4%
Price vs SMA 200
-98.2%
Avg volume (3M)
212,264
Relative volume
0.2
Average dollar volume
$33

Company

3 metrics
Sector
Consumer Cyclical
Industry
Personal Services
Shares outstanding
3.76M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 139.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 4,137,124.1%
P / book
0.0
reciprocal yield 1,108,376.5%
FCF yield
-1,154,178.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-3,175,320.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-52.2%
Trailing 12 months
Net margin
-76.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$8.13M
Net income (TTM)
−$11.94M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-27.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$15.56M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+225.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-286.5%
Return on assets
-49.9%
Debt / equity
2.8
Current ratio
0.4
EBITDA (TTM)
−$6.96M
Free cash flow (TTM)
−$4.34M
Quick ratio
0.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$11.18M
Latest balance sheet
Cash & equivalents
$576,246
Total assets
$23.96M
Total debt
$11.76M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.23M
Capital expenditures (TTM)
$108,143
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$139,274
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
0
13F filer change QoQ
-2
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
35.5%
Latest settlement · 44.6 days to cover
Days to cover
44.6d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1939365 CUSIP 45784E304 Visit website